Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (3,230,494)	$ (5,556,339)
Adjustments to reconcile net loss to net cash used in operating activities:
Noncash stock based compensation expense	1,500,825	2,157,385
Shares issued for services		25
Gain on settlement of accrued compensation	(206,000)
Common Stock issued for interest expenses	229,296
Amortization of beneficial conversion feature	919,000
Depreciation and amortization	17,102	14,738
Amortization of future compensation payable	833,333	203,333
Amortization of prepaid assets	149,856
Changes in assets and liabilities:
Accounts receivable	9,888	(9,888)
Other receivable		57,432
Inventory	5,930	(5,930)
Prepaids and deposits	(44,275)	217,113
Long term receivables - net		(141,182)
Accounts payable	(232,341)	(222,140)
Accrued interest	(89,755)	396,578
Accrued expenses	(22,649)	(361,266)
Net cash used in operating activities	(160,284)	(3,250,141)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of equipment		(12,419)
Net cash used by investing activities		(12,419)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from sale of common stock	1,644,100	853,999
Purchase and cancellation of stock	(1,300,000)
Repayment of insurance premium loan	(108,064)
Repayment on note payable	(1,372,887)	(31,576)
Proceeds from note payable	4,324,000	2,350,000
Proceeds from SBA loan	132,760
Proceeds from the exercise of stock options and warrants	75,250
Net cash provided by financing activities	3,395,159	3,172,423
Net increase (decrease) in cash and cash equivalents	3,234,875	(90,137)
Cash and cash equivalents, beginning of year	88,415	178,552
Cash and cash equivalents, end of year	3,323,290	88,415
Supplemental Cash Flow Information
Cash paid for interest	143,070	2,914
Cash paid for taxes
Schedule of Non-Cash Information
Insurance financing for prepaid insurance	108,064
Discount on note payable on purchase of Applied Optical Sciences		2,500,000
Amortization of discount on note payable		(28,333)
Common stock issued for accrued interest	32,942
Common stock issued for repayment of convertible notes	5,253,614
Long term investment utilized for cancellation of shares	500,000
Note payable on purchase of Applied Optical Sciences		(2,500,000)
Initial beneficial conversion feature on convertible note	$ 919,000	$ 114,684